Guardian Capital Advisors (Canada)’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-63,690
Closed -$1.45M 162
2022
Q1
$1.45M Buy
63,690
+27,040
+74% +$661K 0.14% 92
2021
Q4
$992K Buy
36,650
+22,255
+155% +$596K 0.1% 102
2021
Q3
$400K Sell
14,395
-1,120
-7% -$31.8K 0.04% 139
2021
Q2
$462K Buy
15,515
+3,805
+32% +$115K 0.05% 136
2021
Q1
$348K Sell
11,710
-5,490
-32% -$161K 0.04% 144
2020
Q4
$373K Buy
17,200
+8,095
+89% +$151K 0.05% 138
2020
Q3
$150K Sell
9,105
-1,475
-14% -$25.4K 0.02% 162
2020
Q2
$175K Buy
+10,580
New +$186K 0.03% 140

Other funds holding BHC

Guardian Capital Advisors (Canada)'s BHC Position: Q2 2022 in Review

Guardian Capital Advisors (Canada) sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 63,690 shares — an estimated $1.45M sold.

Guardian Capital Advisors (Canada) first reported a position in BHC in Q2 2020 and held it in 8 quarters. The position peaked at $1.45M in Q1 2022. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • Guardian Capital Advisors (Canada) reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
  • Guardian Capital Advisors (Canada) sold 63,690 Bausch Health shares in Q2 2022, an estimated $1.45M.
  • Guardian Capital Advisors (Canada) first reported a position in Bausch Health in Q2 2020 and held it in 8 quarters.
  • Guardian Capital Advisors (Canada)'s Bausch Health position peaked at $1.45M in Q1 2022.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Guardian Capital Advisors (Canada)'s 13F filing for Q2 2022, filed 12 Aug 2022.